Clinical Trials · NCT07710430
A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- LG Chem
- Enrollment
- 43
- Start date
- Aug 2026
- Locations
- 1 site, South Korea
- Primary endpoint
- Peak luteinizing hormone (LH) level following gonadotropin-releasing hormone (GnRH) stimulation is < 4 International Units per Liter (IU/L).